Seroprevalence of Toxoplasma gondii in Immunocompromised cancer patients in Basrah Provence, Southern Iraq

Authors

  • Shams AL-Duha E. Jaffer Department of Biology, College of Education for Pure Science, University of Basrah, Basrah, Iraq.
  • Abdul Hussein H. Awad Department of Biology, College of Education for Pure Science, University of Basrah, Basrah, Iraq.

DOI:

https://doi.org/10.56714/bjrs.48.2.6

Keywords:

Toxoplasma gondii, Seroprevalence, Cancer patients, ELISA, Basrah

Abstract

The current study was conducted in Basrah province during the period from Dec. 2020 to Oct. 2021. The purpose of the study was to determine the seroprevalence of IgG and IgM antibodies of toxoplasmosis in cancer patients in Basrah province, southern Iraq, using the enzyme-linked immunosorbent assay (ELISA). This study was conducted on 173 people, including 123 people with cancer who were taking chemotherapy and 25 healthy people as a first control group and 25 people with cancer who were not taking chemotherapy were considered as a second control group. The results showed that the incidence of chronic) IgG) toxoplasmosis was 31 and acute (IgM) toxoplasmosis was 0.8%.

 

Downloads

Download data is not yet available.

References

A.M. Tenter, A.R. Heckeroth, L.M. Weiss, International journal for parasitology 30(12-13), 1217 (2000)

J. Montoya, O. Liesenfeld, Toxoplasmosis Lancet 363(9425), 1965 (2004)

F. Robert – Gangnux, M. Dard, Microbial. Rev. 25, 264 (2012).

R.S. Vaz, P. Rauli, R.G. Mello, M.A.J. Cardoso, Field Actions Science Reports Special Issue 33, (2011).

A. Abdoli, M . Barati, A. Dalimi, Journal of Archives in Military Medicine 4, e41832 (2016).

A. Yacoub, S. Bakr, A. Hameed, A. Al Thamery, M.J. Fartoci, EMHJ-Eastern Mediterranean Health Journal 12 (1-2), 112 (2006)

S. Al-Azizz, M. Thamer, N. Jassim, Al-Qadisiyah Journal of Pure Science 13, 17 (2008).

M.A.H. Al-Saadawi, M.J.A. Al-Khahed, Al-Qadisiyah Journal of Veterinary Medicine Sciences 14(1), 58 (2015).

A. Jemal, F. Bary, M.M. Centr, J. Ferlay, E. Ward, D. Forman, A Cancer. J. Clinicians 6(12), 69 (2011).

N. Alwan, EMHJ - Eastern Mediterranean Health Journal 16(11), 1159 (2010).

R. Hussain, O. Habib, Asian Pacific Journal of Cancer Prevention 16(1), 163 (2015)

L. Wang, L.H.E, Z. Chen, H. Wen, H. Fang, Eastern China Parasites & vectors, 8(1), 162 (2015).

S.S. Youssef, M.M. Mohammad, L.R. Ezz-El-Arab, Macedonian Journal of Medical Sciences 3(4), 640 (2015)

M.M. Sanad, F.A. Thagfan, E.M. Al Olayan, Res. J. Parasitol, 9(2), 55 (2014).

R.M. Manesh, A.H. Safa, S.M. Sharafi, R. Jafari, M. Bahadoran, M. Yousefi, H.Y. Darani, J. Renal. Inj.Prev. 3(4), 87 (2014).

M.I. Ali, W.M. Abd El Wahab, D.A. Hamdy, A.J. Hassan, Journal of Parasitic Diseases 43(3), 464 (2019)

D.W. Shin, D.Y. Cha, Q.J. Hua, G.H. Cha, Y.H. Lee, The Korean journal of parasitology 47(2), 125 (2009).

M.I. Ali, W.M. Abd El Wahab, D.A. Hamdy, A. Hassan, Journal of Parasitic Diseases 43(3), 464 (2019)

R.A. Malek, R. Wassef, E. Rizk, H. Sabry, N. Tadros, A. Boghdady, Asian Pac. J. Cancer. Prev. 19(7), 1987 (2018).

A. Imam, F.G. Al- Anzi, M. AL- Ghasham, M. AL- Suraikh, A. AL- Yahya, Z. Rasheed, Saudi. Med. J. 38(3), 319 (2017).

M. Ghasemian, S.H. Maraghi, J. Saki, M. Pedram, Iranian J. Parasitol 2(4), 1 (2007).

I.A. Al-Tameemi, B.H. Abdullah, S.J. Raisan, World Journal of Pharmaceutical Research 8(1), 193 (2019).

Downloads

Published

30-12-2022

How to Cite

Jaffer, S. A.-D. E., & Awad, A. H. H. (2022). Seroprevalence of Toxoplasma gondii in Immunocompromised cancer patients in Basrah Provence, Southern Iraq. Basrah Researches Sciences, 48(2), 57–64. https://doi.org/10.56714/bjrs.48.2.6

Issue

Section

Articles